NASDAQ:EYEN
Eyenovia Inc. Stock News
$0.81
+0.0960 (+13.48%)
At Close: May 31, 2024
Hollywood Rewind | Red Eye: Beware of delayed flights and attractive strangers!
10:34am, Saturday, 30'th May 2020
Red Eye leans towards the rom-com tropes in the first few minutes of the film, and it really throws you off the scent for some time until we see our leads seated next to each other in a plane.
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q1 2020 Results - Earnings Call Transcript
04:38am, Thursday, 14'th May 2020
Eyenovia, Inc. (NASDAQ:EYEN) Q1 2020 Earnings Conference Call May 13, 2020 16:45 ET Company Participants Tram Bui - Senior Vice President, Investor Relations Se
Eyenovia Reports First Quarter 2020 Financial Results
08:05pm, Wednesday, 13'th May 2020
NEW YORK, May 13, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
8-K: EYENOVIA, INC.
06:01am, Saturday, 09'th May 2020
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 8-K __________________ CURRENT REPORT Pursuant to Section 13...
Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results
12:30pm, Wednesday, 06'th May 2020
NEW YORK, May 06, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
Will Eyenovia Continue to Surge Higher?
02:10pm, Wednesday, 22'nd Apr 2020
As of late, it has definitely been a great time to be an investor Eyenovia
Daily Insider Ratings Round Up 3/25/20
02:25pm, Friday, 27'th Mar 2020
Tables of the top insider purchases and sales filed with the SEC on 3/25/20, based on dollar value. Dollar values often do not equate with significance when it
Insider Buying: Stuart Grant Just Spent US$1.9m On Eyenovia, Inc. (NASDAQ:EYEN) Shares
10:31am, Thursday, 26'th Mar 2020
Eyenovia, Inc. (NASDAQ:EYEN) shareholders (or potential shareholders) will be happy to see that insider Stuart Grant...
Eyenovia (EYEN) Receives a Hold from Oppenheimer
08:59am, Thursday, 26'th Mar 2020
Oppenheimer analyst Esther Rajavelu maintained a Hold rating on Eyenovia (EYEN) today. The company's shares closed last Monday at $2.34. According to
Eyenovia (EYEN) Receives a Hold from Oppenheimer
08:59am, Thursday, 26'th Mar 2020
Oppenheimer analyst Esther Rajavelu maintained a Hold rating on Eyenovia (EYEN – Research Report) today. The company’s shares closed last
Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results
08:05pm, Wednesday, 25'th Mar 2020
NEW YORK, March 25, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
Eyenovia, Inc. to Host Earnings Call
06:30pm, Wednesday, 25'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Eyenovia, Inc. (NASDAQ:EYEN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 4:30 PM E
The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
11:29am, Wednesday, 25'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 24) * BELLUS Health Inc (NASDAQ: BLU) * Global Cord
